Kentucky HB 788: AN ACT relating to buprenorphine products.

Status: returned to Health Services (H) (as of 2025-03-05)

State: Kentucky · Session: 2025RS · Bill: HB 788

Subjects: Administrative Regulations and Proceedings, Boards and Commissions, Drugs and Medicines, Health and Medical Services, Nurses, Physicians and Practitioners, Substance Abuse

View Kentucky HB 788 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.